z-logo
Premium
Peripheral nerve hyperexcitability syndrome: A clinical, electrophysiological, and immunological study
Author(s) -
Wu Yimin,
Shi Jiayu,
Gao Juhua,
Hu Youfang,
Ren Haitao,
Guan Hongzhi,
Li Jing,
Huang Yangyu,
Cui Liying,
Guan Yuzhou
Publication year - 2021
Publication title -
muscle and nerve
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 145
eISSN - 1097-4598
pISSN - 0148-639X
DOI - 10.1002/mus.27188
Subject(s) - fasciculation , medicine , electrophysiology , pathophysiology , pathogenesis , pathology , neuromyotonia , electromyography , antibody , peripheral nerve , anesthesia , immunology , anatomy , physical medicine and rehabilitation
Abstract Introduction Peripheral nerve hyperexcitability syndrome (PNHS) is characterized by muscle fasciculations and spasms. Nerve hyperexcitability and after‐discharges can be observed in electrophysiological studies. Autoimmune mechanisms play a major role in the pathophysiology of primary PNHS. Methods We retrospectively conducted a case–control study recruiting patients with clinical and electrophysiological features of PNHS. Control patients were diagnosed with other neuronal or muscular diseases. Contactin‐associated protein2 (CASPR2) and leucine‐rich glioma‐inactivated1 (LGI1) antibodies were examined. Results A total of 19 primary PNHS patients and 39 control patients were analyzed. The most common symptoms for the case group were fasciculations (11/19) and muscle spasms (13/19). Case group patients were likely to demonstrate electrodiagnostic findings of nerve hyperexcitability (17/19) and after‐discharges in the tibial nerve (19/19). We found high prevalence of CASPR2 (9/19) and LGI1 (6/19) antibodies in the case group. Discussion Primary PNHS patients were likely to show after‐discharges in the tibial nerve. The pathogenesis of PNHS is autoimmune CASPR2 and LGI1 antibodies are possible pathogenic antibodies for primary PNHS.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here